Annual Congress Copenhagen 2005

Saturday, 17.09.2005
Sunday, 18.09.2005
Monday, 17.09.2005
Tuesday, 20.09.2005
Wednesday, 21.09.2005

Citations should be made in the following way: Authors. Title. Eur Respir J 2005; 26: Suppl. 49, abstract number.

Material from 2005:

4063 Abstracts
739 Slide presentations
213 Webcasts
93 Handouts

Material from 2005: Show

Treatment of tuberculosis in susceptible and MDR patients

Thematic Poster Session
Chairs: R. Zaleskis (Copenhagen, Denmark), P. D. O. Davies (Liverpool, United Kingdom)

Download all media

Evaluation of relapse and defaulter pulmonary tuberculosis patients A. Baran, A. Aybatli, S. Bilgin, E. Damadoglu, U. Bayram, E. Akkaya (Istanbul, Turkey)
Management of tuberculosis contacts in a pediatric population in Santiago, Chile C. Pierry, M. Aceituno, V. Duran (Santiago, Chile)
Follow up of newly detected patients with destructive lung tuberculosis who were failed at the end of 8-month chemotherapy S. A. Cherenko, O. E. Begoulyev (Kiev, Ukraine)
Disorder of liver function tests (LFT) induced by antituberculous drugs (ATD) S. N. Golubovic, I. N. Djordjevic, M. M. Radovic, G. J. Pejovic, V. S. Djordjevic (Nis, Serbia And Montenegro)
Results of DOTS strategy within the tuberculosis control program in Bucharest, Romania C. D. Marica, C. Didilescu, V. Spinu (Bucharest, Romania)
Clinical, radiological, and bacteriological features of tuberculosis (TB) in teenagers' initial treatment and outcome L. Jandric, K. Jandric, J. Bojanic, B. Kuzmic (Banja Luka, Bosnia And Herzegovina)
Arterial bilateral embolisation in evolutive tuberculosis: one case report R. Mahouachi, R. El Gharbi, S. Taktak, A. Chtourou, N. Dreepaul, R. Ben Chaaben, A. Ben Kheder (Ariana, Tunisia)
Chemotherapy efficacy in TB patients resistant to major and reserve drugs V. Y. Mishin (Moscow, Russian Federation)
Risk factors in tuberculosis and its influence on chemotherapy efficiency A. V. Bogomazova (Minsk, Belarus)
Risk factors for paradoxical response during adequate tuberculosis treatment A. M. Skrahina, H. L. Hurevich, L. K. Surkova, T. A. Skrahina, A. P. Astravko (Minsk, Belarus)
The causes of ineffectiveness of treatment of tuberculosis in children E. A. Rechkina, V. P. Kostromina (Kiev, Ukraine)
Pre-chemotherapy drug sensitivity test for antitubercular drugs in India – is it essential? S. G. Narayan, K. S. Agarwal, A. Shampa (Varanasi, India)
Factors affecting tuberculosis treatment: the beliefs of patients O. Balbay, V. Isikhan, P. Arbak, A. N. Annakkaya, G. Aytar (Duzce, Ankara, Turkey)
Outcome of patients treated for culture-positive pulmonary tuberculosis (CPPTB) in Poland M. Korzeniewska-Kosela, I. Szczuka, J. Kus (Warsaw, Poland)
Treatment approach to tuberculosis in patients with antituberculotic-induced liver disorders D. B. Kukavica, S. I. Pavlovic, Z. A. Markovic, V. N. Kuruc, A. M. Vukelic, T. A. Kurucin, M. P. Ilic (Sremska Kamenica, Serbia And Montenegro)
12-years‘ experience in the direct approach to pulmonary caverna tuberculosis D. M. C. Nicolau (Cluj-Napoca, Romania)
Intravenous ozon in pulmonary tuberculosis N. V. Yahorava, H. L. Hurevich, N. S. Shpakovskay (Minsk, Belarus)
Adverse effects of second-line drugs during the treatment of multidrug resistant tuberculosis patients O. Tümer, S. Öztas, N. Adigüzel, E. Acartürk, Y. Tezel, M. Kurutepe (Istanbul, Turkey)
Tuberculosis in adolescence – identification and treatment of high risk groups/individuals M. M. Radovic, R. Lidija, G. N. Slavica, D. N. Ivanka, G. D. Pejovic, S. P. Zoran (Nis, Serbia And Montenegro)
Impact of pre-test voluntary counseling on notification of HIV-infection in patients with tuberculosis S. A. Cherenko, T. A. Alexandrina, M. S. Cherenko (Kiev, Ukraine)